G vs STE · P/E 16, rev $5.08B vs P/E 25, rev $5.46B
Genpact Limited (G) versus STERIS plc (STE) — a side-by-side from cached financials, not a winner call.
Genpact Limited (G) is a information technology services company listed on US.
STERIS plc (STE) is a medical devices company listed on NYSE.
Latest reported G revenue for 2025-12-31 was $5.08B. Net income was $552.5M. Revenue was up 6.6% from 2024-12-31 to 2025-12-31. G currently screens at market cap $8.07B and trailing P/E 15.5.
Latest reported STE revenue for 2025-03-31 was $5.46B. Net income was $616.1M. Revenue was up 284.6% from 2024-03-31 to 2025-03-31. STE currently screens at market cap $19.43B and trailing P/E 25.1.
G currently screens at market cap $8.07B and trailing P/E 15.5. STE currently screens at market cap $19.43B and trailing P/E 25.1.
Not investment advice. Open the G and STE stock pages for the full models.
Not investment advice.